Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2012
11/22/2012US20120294798 Methods of treating cancer using il-21
11/22/2012US20120294797 Anti-cgrp compositions and use thereof
11/22/2012US20120294796 Antibodies Reactive with B7-H3 and Uses Thereof
11/22/2012CA2836568A1 Immunity induction agent
11/22/2012CA2836556A1 Immunity induction agent
11/22/2012CA2836473A1 Il-12 p40 monomer, monoclonal antibody against p40 homodimer and the combination of the two for autoimmune disease treatment
11/22/2012CA2836468A1 Human immunodeficiency virus neutralizing antibodies and methods of use thereof
11/22/2012CA2836396A1 Method for egfr directed combination treatment of cancer
11/22/2012CA2836273A1 Thermostable vaccine compositions and methods of preparing same
11/22/2012CA2836251A1 Protein matrix vaccine compositions including polycations
11/22/2012CA2836098A1 Hendra and nipah virus g glycoprotein immunogenic compositions
11/22/2012CA2836028A1 Cytotoxic t cell inducer
11/22/2012CA2835972A1 Virus-like particles and process for preparing same
11/22/2012CA2835967A1 Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response
11/22/2012CA2835798A1 Epha4 is a disease modifier in motor neuron disease
11/22/2012CA2835599A1 Osteogenesis promoter
11/22/2012CA2834907A1 Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
11/22/2012CA2834879A1 Fgfr1 agonists and methods of use
11/22/2012CA2834834A1 Vaccine against streptococcus pneumoniae
11/22/2012CA2834566A1 Therapeutic anti-igf1r combinations
11/22/2012CA2832174A1 Antibodies for treatment of cancer expressing claudin 6
11/21/2012EP2524701A2 Pharmaceutical composition and method for producing the same
11/21/2012EP2524700A1 Mucinous glycoprotein (muc-1) vaccine
11/21/2012EP2524699A1 Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties
11/21/2012EP2524693A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
11/21/2012EP2523976A1 Biomarkers of immunomodulatory effects in humans treated with anti-cd200 antibodies
11/21/2012EP2523973A1 Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof
11/21/2012EP2523689A1 Il-22-fc and hepcidin activity
11/21/2012EP2523688A1 Antibody formulation and therapeutic regimens
11/21/2012EP2523687A1 Methods for diagnosis and treatment of cutaneous t cell lymphomas
11/21/2012EP2523686A2 Liver targeting domain antibodies
11/21/2012EP2523685A1 Variants of the group-5 allergens of the poaceae with reduced allergenicity by mutagenesis of proline residues
11/21/2012EP2523684A1 Variants of the group-6 allergens of the poaceae with reduced allergenicity by mutagenesis of proline residues
11/21/2012EP2523683A1 Fusion proteins for delivery of erythropoietin to the cns
11/21/2012EP2523682A2 Notch1 binding agents and methods of use thereof
11/21/2012EP2523681A1 Methods of producing adenovirus vectors and viral preparations generated thereby
11/21/2012EP2523680A1 Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma
11/21/2012CN202537381U Massage aerated closestool pad
11/21/2012CN1891716B No mitogen activity anti CD3 small molecular antibody designing method
11/21/2012CN1835975B Modified human IGF-1R antibodies
11/21/2012CN102791739A Modulators of hepatocyte growth factor activator
11/21/2012CN102791737A Antibodies that specifically bind to the EPHA2 receptor
11/21/2012CN102791735A Monoclonal antibodies to progastrin and their uses
11/21/2012CN102791732A Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof
11/21/2012CN102791293A Liver targeting molecules
11/21/2012CN102791292A Delivery system for diagnostic and therapeutic agents
11/21/2012CN102791291A Non-DNA base-containing polynucleotide compositions and their use for the modulation of immune responses
11/21/2012CN102791290A A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy
11/21/2012CN102791289A Variants of the group-5 allergens of the poaceae with reduced allergenicity by mutagenesis of proline residues
11/21/2012CN102791288A Recombinant attenuated parvovirus
11/21/2012CN102791287A Method for protecting against disease caused by secondary pathogens
11/21/2012CN102791286A Targeted heterologous antigen presentation on calicivirus virus-like particles
11/21/2012CN102787140A Method for preparing and extracting squalene by microalgae
11/21/2012CN102787138A Antibacterial agent and preparation method of antibacterial agent
11/21/2012CN102787119A Products and methods for treatment and/or prevention of virus infections
11/21/2012CN102787100A High-prolificacy porcine circovirus type-2 strain and application thereof
11/21/2012CN102787097A Modified dendritic cell and vaccine containing the same
11/21/2012CN102787074A Microalgae new strain for producing squalene
11/21/2012CN102786592A Specific HBV antibody
11/21/2012CN102786582A Tem8 peptides and vaccines comprising the same
11/21/2012CN102784392A Methods and compositions for use in treatment of patients with autoantibody positive disease
11/21/2012CN102784391A IL-23 and its receptor
11/21/2012CN102784390A Method for preparing thermal-stability vaccine
11/21/2012CN102784389A Preparation method of Mycobacterium tuberculosis Ag85A oral DNA vaccine
11/21/2012CN102784385A Peptide selection method
11/21/2012CN102274165B Ointment based on anti-TNF-alpha monoclonal antibody used for treating psoriasis
11/21/2012CN102210860B Mycobacterium tuberculosis TB10.4-F1 fusion protein vaccine and preparation method thereof
11/21/2012CN102210859B Mycobacterium tuberculosis ESAT-6-F2 fusion protein subunit vaccine and preparation method thereof
11/21/2012CN102181450B Trichina Ts27 gene, encoding protein and application thereof
11/21/2012CN102174477B Hepatitis A virus strain SH and diploid cell adaptation method thereof
11/21/2012CN102174476B Inactivated vaccine for preventing duck virus hepatitis and preparation method thereof
11/21/2012CN102166350B Flounders quintuplet inactivated vaccine and preparation method thereof
11/21/2012CN102068695B Method for producing quadruple inactivated vaccine for newcastle disease, infectious bronchitis, avian influenza (H9 subtype) and infectious bursal disease
11/21/2012CN102058880B Method for producing trivalent inactivated vaccines for porcine infectious pleuropneumonia
11/21/2012CN101991845B Duck infectious serositis inactivated vaccine emulsification method
11/21/2012CN101954075B Method for preparing oral avian influenza vaccine from transgenic dunaliella
11/21/2012CN101920004B Preparation and application of coconut globulin ferrous complex iron supplement agent
11/21/2012CN101845456B Corn expression vector of tubercle Ag85B gene and application thereof
11/21/2012CN101845449B Fusion gene of Hepatitis B virus L gene and tubercle Esat6 and construction and application of expression vector thereof
11/21/2012CN101580849B Dna-transfection system for generation of infectious influenza virus
11/21/2012CN101491671B Cross-protection vaccine and building method thereof
11/21/2012CN101487009B Method for preparing vaccine for anti-HPV 16 infection by pichia yeast expression system
11/20/2012USRE43823 Human monoclonal antibody against coreceptors for human immunodeficiency virus
11/20/2012US8314067 Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
11/20/2012US8314059 Diabetic nephropathy therapies
11/20/2012US8313944 Methods to cause differentiation of T-cells for use in cell therapy
11/20/2012US8313928 Expression system
11/20/2012US8313913 Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIa
11/20/2012US8313912 Cancer specific oligosaccharide sequences and use thereof
11/20/2012US8313897 Method for preserving viral particles
11/20/2012US8313752 Macrocyclic lactone combination compositions, vaccines and methods for producing same
11/20/2012US8313751 Compositions and methods for the prophylaxis or treatment of viral diseases
11/20/2012US8313750 Enterovirus type 71 protein and method for production
11/20/2012US8313749 genetic vaccines comprising a recombination activating gene (rag) nucleotide sequence, used to code polypeptides, for the prevention and/or treatment of periodontal diseases, caused by infection by Porphyromonas gingivalis
11/20/2012US8313748 Fusion protein vaccine
11/20/2012US8313747 Antikine antibodies that bind to multiple CC chemokines
11/20/2012US8313746 Human monoclonal antibodies against hendra and nipah viruses
11/20/2012US8313745 Compositions against cancer antigen LIV-1 and uses thereof
11/20/2012US8313730 Treatment of celiac disease with IgA
11/20/2012CA2777431A1 Pharmaceutical composition and method for producing the same
1 ... 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 ... 1823